Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin

Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin

Abstract Background Long‐term sequelae of acute pulmonary embolism (PE) include decreased quality of life (QoL). Evidence suggests that adequacy of initial anticoagulant treatment in the acute phase of venous thrombosis has a key impact on late postthrombotic complications. We hypothesize that patie...

Full description

Bibliographic Details
Main Authors: Roisin Bavalia, Ingrid M. Bistervels, Wim G. Boersma, Isabelle Quere, Dominique Brisot, Nicolas Falvo, Dominique Stephan, Francis Couturaud, Sebastian Schellong, Jan Beyer‐Westendorf, Karine Montaclair, Waleed Ghanima, Marije ten Wolde, Michiel Coppens, Emile Ferrari, Olivier Sanchez, Patrick Carroll, Pierre‐Marie Roy, Susan R. Kahn, Karina Meijer, Simone Birocchi, Michael J. Kovacs, Amanda Hugman, Hugo ten Cate, Hilde Wik, Gilles Pernod, Marie‐Antoinette Sevestre‐Pietri, Michael A. Grosso, Minggao Shi, Yong Lin, Barbara A. Hutten, Peter Verhamme, Saskia Middeldorp, the Hokusai post‐PE study investigators
Format: Article
Language:English
Published: Wiley 2021-07-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
edoxaban
pulmonary embolism
quality of life
warfarin
Online Access:https://doi.org/10.1002/rth2.12566

Similar Items

Similar Items